MJNA OTC
Medical Marijuana, Inc.
1W: -50.0%
1M: +0.0%
3M: +0.0%
YTD: -66.7%
1Y: -66.7%
3Y: -98.3%
5Y: -99.7%
$0.00
-0.00 (-33.33%)
Weekly Expected Move ±106.3%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$15M
-11.3% ▼
5Y CAGR: -27.7%
Gross Profit
$12M
+3.7% ▲
5Y CAGR: -27.4%
Operating Income
-$1K
+100.0% ▲
Net Income
-$642K
+87.4% ▲
EPS (Diluted)
$-0.00
+91.7% ▲
EBITDA
-$74K
+98.4% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $47M | $34M | $25M | $17M | $15M |
| YoY Growth | -37.9% | -27.3% | -26.4% | -33.0% | -11.3% |
| Cost of Revenue | $9M | $7M | $7M | $6M | $3M |
| Gross Profit | $38M | $27M | $18M | $11M | $12M |
| Gross Margin | 80.4% | 78.7% | 73.5% | 66.9% | 78.2% |
| R&D Expenses | $77K | $0 | $0 | $0 | $0 |
| SG&A Expenses | $40M | $29M | $23M | $15M | $12M |
| Operating Expenses | $40M | $29M | $23M | $16M | $12M |
| Operating Income | -$2M | -$2M | -$5M | -$4M | -$1K |
| Operating Margin | -4.6% | -5.2% | -18.7% | -26.7% | -0.0% |
| Interest Expense | $743K | $255K | $52K | $116K | $294K |
| Income Before Tax | -$96M | -$5M | -$15M | -$5M | -$642K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$96M | -$5M | -$15M | -$5M | -$642K |
| Net Margin | -204.1% | -14.0% | -61.2% | -30.2% | -4.3% |
| EPS (Diluted) | $-0.03 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
| EBITDA | -$95M | -$4M | -$15M | -$5M | -$74K |
| Shares Outstanding | 3.17B | 3.65B | 3.66B | 4.25B | 6.77B |